TEAS Plus New Application

APADAZ

KemPharm, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 88217332
Filing Date: 12/05/2018

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK \\TICRS\EXPORT17\IMAGEOUT 17\882\173\88217332\xml1\ FTK0002.JPG
*SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT APADAZ
*COLOR MARK NO
*COLOR(S) CLAIMED
(If applicable)
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word APADAZ with an equilateral triangle, composed of three triangles that are separate from each other, located to the right of APADAZ.
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT 1457 x 600
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK KemPharm, Inc.
*STREET 2500 Crosspark Rd., Suite E126
*CITY Coralville
*STATE
(Required for U.S. applicants)
Iowa
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
52241
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder, pain, central nervous system disorders, and psychiatric diseases and disorders
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
The applicant claims ownership of active prior U.S. Registration Number(s) 5519982. 
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Christopher J. Voci
ATTORNEY DOCKET NUMBER 123307.043
FIRM NAME Simmons Perrine Moyer Bergman PLC
STREET 1150 - 5th Street, Suite 170
CITY Coralville
STATE Iowa
COUNTRY United States
ZIP/POSTAL CODE 52241
PHONE 319-354-1019
FAX 319-354-1760
EMAIL ADDRESS trademarks@spmblaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Gregory G. Williams
CORRESPONDENCE INFORMATION
*NAME Christopher J. Voci
FIRM NAME Simmons Perrine Moyer Bergman PLC
*STREET 1150 - 5th Street, Suite 170
*CITY Coralville
*STATE
(Required for U.S. addresses)
Iowa
*COUNTRY United States
*ZIP/POSTAL CODE 52241
PHONE 319-354-1019
FAX 319-354-1760
*EMAIL ADDRESS trademarks@spmblaw.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
FEE PER CLASS 225
*TOTAL FEE PAID 225
SIGNATURE INFORMATION
* SIGNATURE /Robert Hoag/
* SIGNATORY'S NAME Robert Hoag
* SIGNATORY'S POSITION Associate General Counsel, KemPharm, Inc.
SIGNATORY'S PHONE NUMBER 3212501949
* DATE SIGNED 12/05/2018



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 88217332
Filing Date: 12/05/2018

To the Commissioner for Trademarks:

MARK: APADAZ (stylized and/or with design, see mark)

The mark in your application is APADAZ.
The applicant is not claiming color as a feature of the mark. The mark consists of the word APADAZ with an equilateral triangle, composed of three triangles that are separate from each other, located to the right of APADAZ.
The applicant, KemPharm, Inc., a corporation of Delaware, having an address of
      2500 Crosspark Rd., Suite E126
      Coralville, Iowa 52241
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
       International Class 005:  Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder, pain, central nervous system disorders, and psychiatric diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).



Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 5519982.


The applicant's current Attorney Information:
      Christopher J. Voci and Gregory G. Williams of Simmons Perrine Moyer Bergman PLC      1150 - 5th Street, Suite 170
      Coralville, Iowa 52241
      United States
      319-354-1019(phone)
      319-354-1760(fax)
      trademarks@spmblaw.com (authorized)
The attorney docket/reference number is 123307.043.

The applicant's current Correspondence Information:
      Christopher J. Voci
      Simmons Perrine Moyer Bergman PLC
      1150 - 5th Street, Suite 170
      Coralville, Iowa 52241
      319-354-1019(phone)
      319-354-1760(fax)
      trademarks@spmblaw.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Plus status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Robert Hoag/   Date: 12/05/2018
Signatory's Name: Robert Hoag
Signatory's Position: Associate General Counsel, KemPharm, Inc.
Signatory's Phone Number: 3212501949
Payment Sale Number: 88217332
Payment Accounting Date: 12/06/2018

Serial Number: 88217332
Internet Transmission Date: Wed Dec 05 09:46:56 EST 2018
TEAS Stamp: USPTO/FTK-XXX.XXX.XX.XX-2018120509465637
0112-88217332-610c32eb82ec789dbc6b888eba
a82dde522df89d36d97159e1fbf30b31b71f8b2-
CC-8675-20181204152135203798

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed